San Diego, CA, United States of America

Imcor Pharmaceutical Company


USPTO Granted Patents = 6

% Expired Patents = 100.0


Forward Citations = 25

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Ernest George Schutt (6 out of 67 patents)

silverMedal Jeffry G Weers (3 out of 60 patents)

bronzeMedal David P Evitts (3 out of 13 patents)

4.  Charles David Anderson (3 out of 13 patents)

5.  Rene Alta Kinner (2 out of 6 patents)

6.  Thomas E Tarara (1 out of 38 patents)

7.  Leo A Trevino (1 out of 6 patents)

8.  David H Klein (1 out of 9 patents)

9.  Alexey S Kabalnov (1 out of 77 patents)


6 patents:

Company Overview
Imcor Pharmaceutical Company is a leading pharmaceutical company specializing in the development and manufacturing of high-quality generic and branded pharmaceutical products. With a strong focus on research and development, Imcor is committed to providing innovative and cost-effective healthcare solutions to patients worldwide. Our state-of-the-art facilities and experienced team of professionals ensure the highest standards of quality and safety in all our products, making us a trusted partner for healthcare providers and patients alike.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#762 in San Diego, CA

#10,578 in California

#45,007 in US

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 25

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Imcor Pharmaceutical Company. Retrieved from https://idiyas.com/company/imcor-pharmaceutical-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…